IBM's Watson supercomputer celebrated the second anniversary of its trouncing human competitors on "Jeopardy" with the announcement of two new medical applications aimed at helping battle cancer. In the past year, IBM has partnered separately with the Memorial Sloan-Kettering Cancer Center (MSK) and WellPoint to develop Watson health care products starting in the areas of oncology and utilization management.